GL1X · GenesisL1 explorer

MolNFT v1 · #28710 · protein

Crystal structure of the CDC25B phosphatase catalytic domain in the apo form

1YMK · M-phase inducer phosphatase 2: “Crystal structure of the CDC25B phosphatase catalytic domain in the apo form”. X-ray diffraction, 1 ligand (CL), 2 pockets (best druggability 0.50). MolNFT v1 #28710 on GenesisL1: 3D structure…

PDB
1YMK
Type
protein
Length
171 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
M-phase inducer phosphatase 2
EC
3.1.3.48
UniProt
P30305
Ligands
CL
Pockets
2 · best druggability 0.50

Structure

x-ray diffraction · 1 distinct chain · 33% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AM-phase inducer phosphatase 2 (EC 3.1.3.48)protein17133% helix, 18% strandP30305

Ligands and binding sites

  • CL · Chloride ion · ion · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1970.500.8217CL
2790.380.7716empty

Compared structures

  • 1YMK · Crystal Structure of the CDC25B phosphatase catalytic domain in the apo form · the same entry in another collection · chain A against A, TM-score 1.00
  • P30305 · AlphaFold monomer V2.0 prediction for M-phase inducer phosphatase 2 (P30305) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.